You are here » Home » Companies » Company Overview » Medico Remedies Ltd

Medico Remedies Ltd.

BSE: 540937 Sector: Health care
NSE: N.A. ISIN Code: INE630Y01016
BSE 00:00 | 17 Sep 245.00 10.00
(4.26%)
OPEN

245.00

HIGH

245.00

LOW

245.00

NSE 05:30 | 01 Jan Medico Remedies Ltd
OPEN 245.00
PREVIOUS CLOSE 235.00
VOLUME 1200
52-Week high 245.00
52-Week low 73.20
P/E 39.20
Mkt Cap.(Rs cr) 102
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 245.00
CLOSE 235.00
VOLUME 1200
52-Week high 245.00
52-Week low 73.20
P/E 39.20
Mkt Cap.(Rs cr) 102
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Medico Remedies Ltd. (MEDICOREMEDIES) - Company History

Medico Remedies Limited was incorporated as a private limited company with the name 'Medico Remedies Private Limited' on March 18 1994. The status of the Company was changed to a public limited company and the name of the Company was changed to Medico Remedies Limited on March 6 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective Beta-Lactums cephalosporins antimalarial antiretroviral anti-ulcer drugs and antacids vitamins haematinics and other supplements. Further in addition to the above the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS antihistaminic antidiabetics cardio vascular drugs diuretics anti-epileptics combination drug kits syrups and cream & gel for various therapeutic segments.The Company began its operations in the year 1994 with manufacturing and servicing of diuretics anti-malarials NSAIDS tablets anti-reterovirals anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion in the year 1999 & 2002 the company has acquired two adjacent plots of 1023.50 sq. metres each respectively for setting up the plant at Palghar Maharashtra. The plant is divided into two units i.e. general formulations unit and betalactam unit; the beta lactam unit is further divided into two segments -penicillin and cephalosporins.The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited Saad Medical Manfes Pharmaceuticals & Chemical Industries Award Global Company Limited Directorate of Health Services (DHS Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license FPS license and MESI license.

.